Rolf A. Classon

Former Interim Chief Executive Officer at Hill-Rom Company, Inc.

Rolf A. Classon

Rolf A. Classon

Former Interim Chief Executive Officer at Hill-Rom Company, Inc.

Career Highlights

Pharmacia AB
Bayer Diagnostics Corp.
Pharmacia Biosystems AB

RelSci Relationships


Number of Boards






Contact Data
Trying to get in touch with Rolf A. Classon? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
RelSci Relationships are individuals Rolf A. Classon likely has professional access to. A relationship does not necessarily indicate a personal connection.

Director at PTS Intermediate Holdings LLC

Relationship likelihood: Strong

Founder at Worthy Ventures Resources, LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Assertio Therapeutics, Inc.

Relationship likelihood: Strong

Chair & Chief Executive Officer at Catalent, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Director at Hill-Rom, Inc.

Relationship likelihood: Strong

Senior Vice President, Corporate Affairs & Chief Legal Officer at Hill-Rom, Inc.

Relationship likelihood: Strong

Member-New York Chapter at National Association of Corporate Directors (New York)

Relationship likelihood: Strong

Catalent Pharma Solutions, Inc.

Relationship likelihood: Strong

Executive Chairman at Hill-Rom Holdings, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Hill-Rom Holdings, Inc.

Relationship likelihood: Strong

Paths to Rolf A. Classon
Potential Connections via
Relationship Science
Rolf A. Classon
Former Interim Chief Executive Officer at Hill-Rom Company, Inc.
Chemical Engineering
Class of 1969

University of Gothenburg is a school in Gothenburg.

Career History
Senior Advisor
2015 - Current

BBHCP is an active manager which seeks to invest $10 to $120 million in leading companies with enterprise values of $10 million to $500 million and can invest substantially more by partnering with strategic co-investors or through co-investments from their limited partners. They focus on companies operating across a broad range of sectors including business services, education, information, media & publishing, financial services & insurance, government services, logistics and outsourced business services.The firm seeks both minority as well as majority shareholding positions in portfolio companies and provides capital through a range of transactions including MBOs, LBOs, buy-and-build strategies, growth financings, ownership transitions & generational transfers, recapitalizations and acquisitions transactions.

Interim Chief Executive Officer
2005 - Current

Hill-Rom is an American company focused on medical technologies for the health care industry. Hill-Rom's product portfolio includes patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products, and information technology solutions.

Senior Member of the Advisory Board

Brown Brothers Harriman & Co. is a broker/dealer located in New York City. The firm provides a comprehensive range of equity execution services exclusively to institutional clients worldwide. Their clients include private banks, mutual funds, hedge funds, independent asset managers and investment advisors and other brokers.

Boards & Committees
2011 - 2011

EKR Therapeutics, Inc. is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader therapeutic options and greater control to improve in-patient care, speed recovery, and achieve optimal outcomes. Backed by the strength of its award winning management team, the dedication of its field force of product specialists and its commitment to excellence in customer service and medical education, EKR has been organized to be a class leader in commercializing products to address unmet and under-satisfied medical needs or to otherwise enhance the therapeutic value of acute-care products.

2007 - 2010

Swedish Orphan International Holding AB is an international group with its head office in Stockholm, Sweden. The original company was formed in 1988, taking as its starting point the US Orphan Drug Act of 1983.In 2004, the company was acquired by a consortium consisting of Investor Growth Capital, Skandia Investment and the management of Swedish Orphan International AB. The operating companies are Swedish Orphan International and its subsidiaries in Europe and Japan.The organizational structure is primarily based on a logistical perspective. In order to reach patients in emergency situations, regardless of where they are, it needs an extensive organization with strong local roots and the ability to see things in a larger perspective. The better and broader its partnerships, the more effectively the firm can work and the greater the synergies that it can achieve between the various markets.

Member, Board of Directors
2005 - 2010

EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Rolf A. Classon. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Rolf A. Classon's profile does not indicate a business or promotional relationship of any kind between RelSci and Rolf A. Classon.